PharmaMar’s Aplidin In The Spotlight Again As Top EU Court Sets Aside Earlier Ruling On Approval
Executive Summary
The Court of Justice says that the General Court was wrong to consider two experts from a university hospital as employees of a pharmaceutical company solely because the hospital housed a cell therapy research center.